NVAX Stock Gains 12% on Q1 Earnings & Sales Beat, '25 Sales View Up

Novavax (NVAX) reported first-quarter 2025 earnings of $2.93 per share, which beat the Zacks Consensus Estimate of 71 cents. In the year-ago quarter, the company reported a loss of $1.05 per share.Quarterly revenues totaled $667 million compared with $94 million in the year-ago period. The reported figure beat the Zacks Consensus Estimate of $212 million. (Find the latest EPS estimates and surprises on Zacks Earnings Calendar)More on NVAX’s EarningsNovavax recorded $622 million in product sales compared wit ...